EUCTR2006-003667-31-DE进行中（未招募）不适用
Prednisolone vs. Ciclosporine in Severe Atopic Eczema. PROVE - Study - PROVE
Medical Faculty, TU Dresden0 个研究点目标入组 66 人开始时间: 2007年4月23日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 66
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- age 18-55 years
- •- weight 50 -100 kg
- •- severe atopic eczema (oSCORAD > 40 Punkte, resistant to topical treatment)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years)
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- pregnancy / nursing mothers
- •- Women in reproductive age without adequate contraception
- •- acute infection (bacterial / viral)
- •- malignancy in personal history
- •- concommitant diabetes mellitus, hypertension, glaucoma, osteoporosis, ulcus ventriculi / duodeni, chronic hepatitis B, severe hepatopathy, AND/OR nephropathy,
- •- UV-Therapy in past 8 weeks
- •- alcohol AND/OR drug abuse
研究者
相似试验
进行中（未招募）
不适用
Prednisolone vs. Ciclosporine in Severe Atopic Eczema. PROVE - Study - PROVEatopic eczemaMedDRA version: 8.1Level: LLTClassification code 10003641Term: Atopic eczemaEUCTR2006-003667-31-ATMedical Faculty, TU Dresden66
已完成
4 期
Prednisolone vs. Ciclosporine in Severe Atopic EczemaAtopic DermatitisNCT00445081Technische Universität Dresden66
进行中（未招募）
不适用
Ciclosporin vs. Alitretinoin for severe atopic hand dermatitis. A randomized controlled investigator-initiated double-blind trial. - TocyChronic atopic hand dermatitis, not responding to potent topical corticosteroids.EUCTR2009-017520-88-DEMedical Faculty, TU Dresden78
终止
4 期
Ciclosporin Versus Alitretinoin for Severe Atopic Hand Dermatitis.Atopic DermatitisNCT01231854Technische Universität Dresden15
招募中
1 期
Optimization of Cyclosporin therapy in atopic dermatitis through multiomic predictive models of treatment response (DermAtOmics)Adult, adolescent and paediatric patients with moderate-severe atopic dermatitisCTIS2022-500677-14-00Fundación Para La Investigación Biomédica Del Hospital Universitario La Paz100